ArticleCase reports in medicine2026
Controlled Heel-Site Arteriovenous Vent via Venous Reimplantation on PTFE-Tibial Bypass: A Novel Adjunct in No-Vein Chronic Limb-Threatening Ischemia.
Article in Case reports in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In no-vein chronic limb-threatening ischemia (CLTI), infrapopliteal prosthetic bypass remains a limb-salvage option but is limited by high distal resistance and graft-artery compliance mismatch. Standard distal adjuncts, including vein cuffs, patches, or distal arteriovenous fistulas, may be technically demanding when local tibial venous anatomy and the confined distal exposure do not allow a reliable conventional configuration. We describe a compact heel-site bypass-to-vein vent based on direct end-to-side venous reimplantation onto the PTFE graft immediately proximal to the arterial heel. Case Presentation: A controlled heel-site arteriovenous vent was created immediately proximal to the arterial heel of a distal polytetrafluoroethylene (PTFE)-anterior tibial artery (ATA) anastomosis in a 75-year-old man with recurrent CLTI, prior failed revascularizations, no usable autologous conduit, and single-vessel tibial runoff through the ATA. Intraoperative assessment showed paired deep veins accompanying the ATA of approximately 2.0-2.5 mm in external diameter with thin walls, making a conventional distal AVF/interposition configuration technically unfavorable. A calibrated oval venotomy was fashioned on the distal PTFE graft, and the proximal stump of the anterior tibial vein was reimplanted end-to-side onto the graft with an oblique takeoff to create a short, controllable bypass-to-vein vent. Results: Postoperative computed-tomography angiography and serial duplex ultrasound surveillance demonstrated sustained patency of both the PTFE-ATA bypass and the heel-site vent, without hemodynamically significant stenosis, excessive shunting, venous hypertension, distal steal, graft thrombosis, or reintervention at 6 months. Rest pain resolved, and baseline ambulation was restored. Conclusions: This heel-site arteriovenous vent represents a compact, calibratable bypass-to-vein configuration that differs from conventional distal AVF adjuncts by using direct end-to-side venous reimplantation onto the PTFE graft immediately proximal to the arterial heel. Because established distal AVF and vein-cuff adjuncts are supported by a stronger evidence base, this configuration should be considered only as a fallback/adaptive option in selected no-vein CLTI scenarios when standard distal adjuncts are technically infeasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.